This article reviews the principal methods economists and benefit/cost
analysts use in evaluating research. These methods usually involve co
mputing impacts using market information, monetizing the impacts, and
then comparing the value of the impacts with the cost of research. Two
principal measures are common in the literature: surplus measures (co
nsumers' surplus, producers' surplus, and combinations thereof) and pr
oductivity measures (average or marginal contributions of research and
development [R&D] at firm, industry, national, or international level
s). Given known time streams of benefits and costs, internal rates of
return to R&D investments are then computed. The article notes both th
e standard technical difficulties with these approaches and the politi
cal and organizational difficulties in using them.